Theratechnologies EV/EBIT
Mi az Theratechnologies EV/EBIT?
A EV/EBIT az Theratechnologies Inc. - N/A
Mi a EV/EBIT meghatározása?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT a Health Care szektor a NASDAQ-on cégekben a Theratechnologies -hoz képest
Mit csinál Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
ev/ebit -hoz hasonló cégek Theratechnologies
- DATATRAK International nak EV/EBIT N/A van
- New York Mortgage Trust Inc nak EV/EBIT N/A van
- Surface Oncology Inc nak EV/EBIT N/A van
- Deciphera Pharmaceuticals Inc nak EV/EBIT N/A van
- Nymox Pharmaceutical Corp nak EV/EBIT N/A van
- Walker River Resources nak EV/EBIT N/A van
- Theratechnologies nak EV/EBIT N/A van
- Palred Technologies nak EV/EBIT N/A van
- Eton Pharmaceuticals nak EV/EBIT N/A van
- The Very Good Food nak EV/EBIT N/A van
- Jangada Mines Plc nak EV/EBIT N/A van
- Northern Lion Gold nak EV/EBIT N/A van
- Just Plc nak EV/EBIT N/A van